Switch to:

10x Genomics Gross Profit

: $202.0 Mil (TTM As of Mar. 2020)
View and export this data going back to 2019. Start your Free Trial

10x Genomics's gross profit for the three months ended in Mar. 2020 was $56.8 Mil. 10x Genomics's gross profit for the trailing twelve months (TTM) ended in Mar. 2020 was $202.0 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. 10x Genomics's gross profit for the three months ended in Mar. 2020 was $56.8 Mil. 10x Genomics's Revenue for the three months ended in Mar. 2020 was $71.9 Mil. Therefore, 10x Genomics's Gross Margin % for the quarter that ended in Mar. 2020 was 78.99%.

10x Genomics had a gross margin of 78.99% for the quarter that ended in Mar. 2020 => Durable competitive advantage

During the past 3 years, the highest Gross Margin % of 10x Genomics was 85.14%. The lowest was 75.18%. And the median was 80.41%.


10x Genomics Gross Profit Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

10x Genomics Annual Data
Dec17 Dec18 Dec19
Gross Profit 60.53 117.65 184.86

10x Genomics Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Gross Profit Premium Member Only Premium Member Only Premium Member Only 39.61 40.81 45.73 58.71 56.80

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


10x Genomics Gross Profit Distribution

* The bar in red indicates where 10x Genomics's Gross Profit falls into.



10x Genomics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

10x Genomics's Gross Profit for the fiscal year that ended in Dec. 2019 is calculated as

Gross Profit (A: Dec. 2019 )=Revenue - Cost of Goods Sold
=245.893 - 61.033
=184.9

10x Genomics's Gross Profit for the quarter that ended in Mar. 2020 is calculated as

Gross Profit (Q: Mar. 2020 )=Revenue - Cost of Goods Sold
=71.905 - 15.108
=56.8

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2020 was 40.813 (Jun. 2019 ) + 45.727 (Sep. 2019 ) + 58.707 (Dec. 2019 ) + 56.797 (Mar. 2020 ) = $202.0 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

10x Genomics's Gross Margin % for the quarter that ended in Mar. 2020 is calculated as

Gross Margin % (Q: Mar. 2020 )=Gross Profit (Q: Mar. 2020 ) / Revenue (Q: Mar. 2020 )
=(Revenue - Cost of Goods Sold) / Revenue
=56.8 / 71.905
=78.99 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


10x Genomics  (NAS:TXG) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

10x Genomics had a gross margin of 78.99% for the quarter that ended in Mar. 2020 => Durable competitive advantage


10x Genomics Gross Profit Related Terms


10x Genomics Gross Profit Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)